A 14-year-old boy with septic shock was admitted to the hospital. One week before admission, he developed cough, congestion, and low-grade fevers followed by complaints of a sore throat 4 days before admission. He developed bilateral conjunctivitis and swelling of the lips with ulcerations 2 days before admission. On arrival to the emergency department, he was febrile, tachycardic, and hypotensive. He was treated with intravenous fluids and a continuous dopamine infusion and transferred to the pediatric inpatient unit.
A 14-year-old boy with septic shock was admitted to the hospital. One week before admission, he developed cough, congestion, and low-grade fevers followed by complaints of a sore throat 4 days before admission. He developed bilateral conjunctivitis and swelling of the lips with ulcerations 2 days before admission. On arrival to the emergency department, he was febrile, tachycardic, and hypotensive. He was treated with intravenous fluids and a continuous dopamine infusion and transferred to the pediatric inpatient unit.
PAST MEDICAL HISTORY
Four years before admission, the patient had presented to the emergency department with similar symptoms and at that time was noted to have oral ulcers, conjunctival injection, and fever. During the evaluation, no laboratory testing was performed, and the patient was discharged with supportive care. He had no other significant past medical history other than asthma.
MEDICATIONS
The patient was taking no medications before presentation.
FAMILY HISTORY
The patient's parents are originally from Ethiopia. The father stated that he had experienced similar symptoms (lip swelling and painful oral lesions but no rash) during his adolescence. He had received no antibiotics, and his lesions spontaneously resolved over 3 months.
PHYSICAL EXAMINATION
The patient's weight and height (52 kg and 172 cm, respectively) were appropriate for his age. His vital signs before the administration of dopamine and intravenous fluids included a blood pressure of 84/29 mm Hg, a pulse of 127 beats per minute, a temperature of 39.2°C, and a respiratory rate of 22 breaths per minute. Significant clinical findings included the presence of conjunctivitis bilaterally with chemosis, swollen lips (Figure 1 ), multiple small tender whitish ulcerations on his tongue and buccal cavities, and exudate in the posterior pharynx along with ulcerations.
LABORATORY AND RADIOGRAPHIC FINDINGS
The patient's white blood cell count was 11 × 10 His inflammatory markers were elevated (C-reactive protein, 7 mg/dL [reference range, <1 mg/dL]; erythrocyte sedimentation rate, 31 mm/hour (reference range, <20 mm/hour). Results of a urinalysis were normal, and results of serum chemistry testing (liver enzymes, bilirubin, blood urea nitrogen, creatinine, and glucose levels) were within their reference range except for serum sodium, which was 131 mmol/L (reference range, 133-143 mmol/L). Test results of a surface swab from the patient's lips to detect herpes via polymerase chain reaction (PCR) assay and a nasopharyngeal swab to detect common viruses such as respiratory syncytial virus, human metapneumovirus, influenza, parainfluenza, rhinovirus, and adenovirus were negative. Blood, fungal, respiratory, and urine cultures showed no growth. A chest radiograph (Figure 2 ) revealed dense consolidation in the left lower lobe, which was consistent with pneumonia.
CLINICAL COURSE BEFORE DIAGNOSIS
Broad-spectrum antibiotic therapy was initiated with vancomycin and ampicillin-sulbactam because the source of infection was unknown, and the infectious disease team was concerned about a bacterial infection. Intravenous fluid resuscitation and dopamine infusion were initiated; the dopamine was weaned gradually and discontinued after a few hours. 
DIAGNOSTIC PROCEDURE AND RESULTS
The detection of Mycoplasma via nasopharyngeal DNA PCR testing confirmed the diagnosis of Mycoplasma-induced rash and mucositis (MIRM).
DIAGNOSIS
The patient was diagnosed with Mycoplasma-induced rash and mucositis.
TREATMENT AND FOLLOW-UP
Ampicillin-sulbactam was continued for a total of 10 days to treat for culture-negative sepsis. Vancomycin was discontinued after 3 days. Results of the positive Mycoplasma testing were returned on day 3 of hospitalization, at which time a 5-day course of azithromycin therapy was instituted. By the sixth day of hospitalization, the patient's mucositis began improving slightly and resolved gradually over 6 weeks.
BRIEF DISCUSSION AND MAJOR TEACHING POINTS

This case describes a child with MIRM.
Mycoplasma pneumoniae is the best-characterized human Mycoplasma pathogen and is a prominent cause of the atypical pneumonia syndrome. M pneumoniae infects the upper and lower respiratory tracts of children and adults worldwide [1] . Approximately 25% of patients can experience extrapulmonary complications, including severe mucocutaneous blistering lesions [2] . The annual rate of Mycoplasma infection varies, but cyclic epidemics have been observed every 3 to 5 years [1] . Although MIRM can occur at any age, patients are typically young (mean age, 12 years), and there is a male predominance [3, 4] . The pathophysiology of how MIRM causes infection is currently unknown. Skin damage from MIRM might occur secondary to immune complex deposition and complement activation after polyclonal B cell proliferation and antibody production. Another potential pathogenic mechanism for MIRM is molecular mimicry between Mycoplasma P1 adhesion molecules and a keratinocyte antigen [3] . A recurrence rate of 8% and 2 case reports of familial cohorts suggest a genetic susceptibility to MIRM [5, 6] . Prodromal symptoms are nearly universal, with cough, malaise, and fever preceding the eruption by approximately 1 week [3, 4] . Although the 2 most common skin lesion presentations are vesiculobullous and targetoid, the rash can present also as papular, macular, or morbilliform [3] . Cutaneous involvement is generally sparse in almost half of the cases, but it also can be absent. On average, patients with MIRM have at least 2 or more sites of mucosal involvement; the most common sites are oral, ocular, and urogenital [3] . Oral mucosal involvement is nearly universal. Radiographic findings consistent with the diagnosis of pneumonia were positive in 79% of patients in a case series that involved 32 patients [4] .
Key findings that would suggest considering a diagnosis of MIRM instead of erythema multiforme or Stevens-Johnson syndrome include detachment of less than 10% of body surface area, involvement of 2 or more mucosal sites, evidence of atypical pneumonia suggested by clinical symptoms of fever, cough, or positive auscultatory findings, and laboratory findings such as an increase in Mycoplasma immunoglobulin M antibodies, detection of M pneumoniae via PCR or cultures, and/or presence of serial cold agglutinins [3, 4] . The presence of skin lesions is not necessary for diagnosis, because they can be absent in onethird of cases. In 1 study, the sensitivity and specificity of PCR testing for M pneumoniae performed on respiratory tract specimens such as those from a nasal wash, nasopharyngeal swab, or pharyngeal swab were between 80% and 100% [7] .
There are no evidence-based guidelines available to dictate treatment. It is unclear whether antibiotics decrease the incidence or severity of the mucocutaneous eruption, but antibiotic therapy can prevent neurologic and pulmonary complications of M pneumoniae [2] . Patients with MIRM have been treated with antibiotics and/or systemic immunosuppression. The most common antibiotics administered include macrolides; documented failure, relapse, and/or worsening after prescription have been reported in one-third of cases [3, 4] . Given that MIRM might be induced by a hyperinflammatory state, the response seen in patients treated with antibiotics, steroids, and/ or intravenous immunoglobulin might be a result of their antiinflammatory effects [4] .
The role of intravenous immunoglobulin in the treatment of MIRM needs to be investigated further. The overall mortality rate of MIRM is very low (3%), and the fatalities reported were usually a result of pulmonary complications in the preantibiotic era [8, 9] .
In conclusion, although MIRM with or without skin lesions has clinical features that overlap with those of erythema multiforme and Stevens-Johnson syndrome, it has distinct clinical findings and a prognosis that help to distinguish it as a distinct clinical syndrome.
